Global Pharmacovigilance Market Size, Trends & Growth Opportunity, By Type (service and software), By Deployment (In-house and outsource), By End-use (Hospitals, Pharmaceutical, and Others), By Region and Forecast till 2027.
Report ID : QR1001354 | Industries : Chemicals & Materials | Published On :January 2022 | Page Count : 236Global Pharmacovigilance Market
In the pharmaceutical industry, pharmacovigilance is a disciplined innovation. This is an unavoidable aspect of drug discovery and the procedures that have been developed. It identifies risk factors for adverse drug reactions (ADRs), and pharmacovigilance pharmacists ensure that drugs are used safely and appropriately. It also aids in the detection of previously undetected ADRs as well as their interactions with known ADRs. The rising prevalence of diseases such as hypertension, cardiac disorders, and others is driving the pharmacovigilance market players to introduce the most cutting-edge, effective drugs. The International Society of Pharmacovigilance (ISoP) is expected to aid in the adoption of new drugs and improve their proper and safe use around the world.
Drivers:
The market is expected to grow due to the rising prevalence of chronic conditions, which is one of the market's driving factors. The market is growing due to rising adoption of outsourcing services, rising drug consumption, and increasing drug development rates. The pharmaceutical industry's high spending, as well as an increase in adverse drug reactions (ADRs) and medication errors, are propelling the pharmacovigilance market forward. Non-profit organisations' growing awareness of pharmacovigilance may boost market growth.
Know more about this report: request for sample pages
Restraints:
Rapid technological advancements in the field of pharmacovigilance have resulted in an ongoing demand for highly skilled professionals, particularly in developing countries where clinical trials are conducted. Because the recording of data and the structure of reporting in pharmacovigilance is complicated due to the numerous variables involved, technological solutions and their implementation are also complicated. As a result, highly skilled personnel are required to carry out the mission in the most efficient and effective manner possible.
Impact of COVID-19
The growing threat of COVID-19 infection is having a positive impact on market growth. Because several potential therapies are being used to treat COVID-19-induced infection, medical monitoring and safety reporting are critical. COVID-19 infection is being treated with medications like hydroxychloroquine (HCQ), Remdesivir, and Lopinavir/Ritonavir. The possibility of suspected adverse drug reactions for some of these medicines had already been reported to the Uppsala Monitoring Centre's individual case safety reports database, VigiBase (UMC).
Segmentation By Type:
The Global Pharmacovigilance Market is classified on the basis of type into service and software. The Service segment is expected to hold the largest segment of Global Pharmacovigilance Market.
Segmentation By Deployment:
The Global Pharmacovigilance Market is classified on the basis of deployment into in-house and outsource. In-house segment is expected to hold the largest market share of Global Pharmacovigilance Market.
Segmentation By End-use:
The Global Pharmacovigilance Market is classified on the basis of End-use into Hospitals, Pharmaceutical, and Others. The Pharmaceutical segment is expected to hold the largest market share of Global Pharmacovigilance Market.
Segmentation by Region:
The Global Pharmacovigilance Market is classified on the basis of region into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold the largest market share of Global Pharmacovigilance Market.
Competitive Landscape:
The key players of Global Pharmacovigilance Market are IQVIA (US), Covance Inc. (US), Parexel International Corporation (US), Accenture (Ireland), Cognizant (US), Bioclinica (US), Icon plc (Ireland), Quanticate (US), and Pharmaceutical Product Development LLC (US).
Market Taxonomy
By Type
- Service
- Software
By Deployment
- In-house
- Outsource
By End-users
- Hospitals
- Pharmaceutical
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Questions Addressed by the Report
- What are the Key Opportunities in Global Pharmacovigilance Market?
- What will be the growth rate from 2020 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
Global Pharmacovigilance Market Toc
1. Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2. Research Methodology
2.11 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3. Executive Summary
4. Global Pharmacovigilance Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5. Global Pharmacovigilance Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Pharmacovigilance Market Share Analysis, By Product Type
5.3 Global Pharmacovigilance Market Size and Forecast, By Product Type
5.3.1 Service
5.3.2 Software
6. Global Pharmacovigilance Market, By Deployment
6.1 Y-o-Y Growth Comparison, By Deployment
6.2 Global Pharmacovigilance Market Share Analysis, By Deployment
6.3 Global Pharmacovigilance Market Size and Forecast, By Deployment
6.3.1 In-house
6.3.2 Outsource
7. Global Pharmacovigilance Market, By End-use
7.1 Y-o-Y Growth Comparison, By End-use
7.2 Global Pharmacovigilance Market Share Analysis, By End-use
7.3 Global Pharmacovigilance Market Size and Forecast, By End-use
7.3.1 Hospitals
7.3.2 Pharmaceutical
7.3.3 Others
8. Global Pharmacovigilance Market, By Geography
8.1 Global Pharmacovigilance Market Share Analysis, By Geography
8.2 Global Pharmacovigilance Market Size and Forecast, By Geography
9. North America Pharmacovigilance Market Analysis and Forecast (2021-2027)
9.1 Introduction
9.2 North America Pharmacovigilance Market Share Analysis, By Product Type
9.3 North America Pharmacovigilance Market Size and Forecast, By Deployment
9.4 North America Pharmacovigilance Market Size and Forecast, By End-use
9.5 North America Pharmacovigilance Market Size and Forecast, By Country
9.5.1 US
9.5.2 Canada
9.5.3 Mexico
10. Europe Pharmacovigilance Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 Europe Pharmacovigilance Market Share Analysis, By Product Type
10.3 Europe Pharmacovigilance Market Size and Forecast, By Deployment
10.4 Europe Pharmacovigilance Market Size and Forecast, By End-use
10.5 Europe Pharmacovigilance Market Size and Forecast, By Country
10.5.1 UK
10.5.2 Germany
10.5.3 France
10.5.4 Rest of Europe (Russia, Spain, Finland, Denmark, Italy, Greece, and Sweden)
11. Asia Pacific Pharmacovigilance Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Asia Pacific Pharmacovigilance Market Share Analysis, By Product Type
11.3 Asia Pacific Pharmacovigilance Market Size and Forecast, By Deployment
11.4 Asia Pacific Pharmacovigilance Market Size and Forecast, By End-use
11.5 Asia Pacific Pharmacovigilance Market Size and Forecast, By Country
11.5.1 China
11.5.2 India
11.5.3 Japan
11.5.4 South Korea
11.2.5 Rest of Asia Pacific (Hong Kong, Australia, Singapore, New Zealand, Indonesia, Malaysia, and Taiwan)
12. Rest of the World Pharmacovigilance Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Rest of the World Pharmacovigilance Market Share Analysis, By Product Type
12.3 Rest of the World Pharmacovigilance Market Size and Forecast, By Deployment
12.4 Rest of the World Pharmacovigilance Market Size and Forecast, By End-use
12.5 Rest of the World Pharmacovigilance Market Size and Forecast, By Country
12.5.1 Middle East & Africa
12.5.2 South America
13. Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14. Company Profiles
14.1 IQVIA (US)
14.1. Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 Covance Inc. (US)
14.2.1. Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3. Parexel International Corporation (US)
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4. Accenture (Ireland)
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5. Cognizant (US)
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6. Bioclinica (US)
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7. Icon plc (Ireland)
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8. Quanticate (US)
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9. Pharmaceutical Product Development LLC (US)
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies